# Immune Modulation by Parenteral Lipids

> **NCT00734916** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 8 (estimated)

## Conditions studied

- Infections
- Total Parenteral Nutrition

## Interventions

- **DIETARY_SUPPLEMENT:** Parenteral lipid emulsion (Omegaven)
- **DIETARY_SUPPLEMENT:** Parenteral lipid emulsion (Intralipid)
- **DIETARY_SUPPLEMENT:** Parental lipid emulsion (Saline 0.9%)

## Key facts

- **NCT ID:** NCT00734916
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-08
- **Final completion:** 2010-02
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2010-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734916, "Immune Modulation by Parenteral Lipids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00734916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*